XML 41 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
Investments (Tables)
9 Months Ended
Sep. 30, 2015
Investments [Abstract]  
Contract Maturity of Available-for-Sale Securities
The following table summarizes the contract maturity of the available-for-sale securities we held as of September 30, 2015:

One year or less
52%
After one year but within two years
28%
After two years but within three and a half years
20%
Total
100%

Summary of Investments
The following is a summary of our investments (in thousands):

    
Gross Unrealized
  
Other-
Than-
Temporary
Impairment
  
Estimated
 
September 30, 2015
 
Cost
  
Gains
  
Losses
  
Loss
  
Fair Value
 
Available-for-sale securities (1):
          
Corporate debt securities
 
$
178,172
  
$
37
  
$
(88
)
 
$
  
$
178,121
 
Debt securities issued by U.S. government agencies
  
91,609
   
8
   
(6
)
  
   
91,611
 
Debt securities issued by states of the United States and political subdivisions of the states (2)
  
62,048
   
36
   
(59
)
  
   
62,025
 
Total securities with a maturity of one year or less
  
331,829
   
81
   
(153
)
  
   
331,757
 
Corporate debt securities
  
270,045
   
132
   
(701
)
  
   
269,476
 
Debt securities issued by U.S. government agencies
  
30,654
   
19
   
(2
)
  
   
30,671
 
Debt securities issued by states of the United States and political subdivisions of the states
  
61,388
   
28
   
(121
)
  
   
61,295
 
Total securities with a maturity of more than one year
  
362,087
   
179
   
(824
)
  
   
361,442
 
Total available-for-sale securities
 
$
693,916
  
$
260
  
$
(977
)
 
$
  
$
693,199
 
Equity securities:
                    
Regulus Therapeutics Inc.
 
$
7,162
  
$
11,432
  
$
  
$
  
$
18,594
 
Securities included in other current assets
  
880
   
   
   
(880
)
  
 
Total equity securities
 
$
8,042
  
$
11,432
  
$
  
$
(880
)
 
$
18,594
 
Total available-for-sale and equity securities
 
$
701,958
  
$
11,692
  
$
(977
)
 
$
(880
)
 
$
711,793
 


    
Gross Unrealized
  
Other-
Than-
Temporary
Impairment
  
Estimated
 
December 31, 2014
 
Cost
  
Gains
  
Losses
  
Loss
  
Fair Value
 
Available-for-sale securities (1):
          
Corporate debt securities (2)
 
$
219,856
  
$
89
  
$
(89
)
 
$
  
$
219,856
 
Debt securities issued by U.S. government agencies
  
47,496
   
7
   
(27
)
  
   
47,476
 
Debt securities issued by the U.S. Treasury (2)
  
19,008
   
9
   
   
   
19,017
 
Debt securities issued by states of the United States and political subdivisions of the states (2)
  
45,196
   
19
   
(53
)
  
   
45,162
 
Total securities with a maturity of one year or less
  
331,556
   
124
   
(169
)
  
   
331,511
 
Corporate debt securities
  
152,730
   
16
   
(600
)
  
   
152,146
 
Debt securities issued by U.S. government agencies
  
62,530
   
   
(151
)
  
   
62,379
 
Debt securities issued by states of the United States and political subdivisions of the states
  
60,073
   
32
   
(234
)
  
   
59,871
 
Total securities with a maturity of more than one year
  
275,333
   
48
   
(985
)
  
   
274,396
 
Total available-for-sale securities
 
$
606,889
  
$
172
  
$
(1,154
)
 
$
  
$
605,907
 
Equity securities:
                    
Regulus Therapeutics Inc.
 
$
12,477
  
$
69,404
  
$
  
$
  
$
81,881
 
Securities included in other current assets
  
880
   
   
   
(880
)
  
 
Total equity securities
 
$
13,357
  
$
69,404
  
$
  
$
(880
)
 
$
81,881
 
Total available-for-sale and equity securities
 
$
620,246
  
$
69,576
  
$
(1,154
)
 
$
(880
)
 
$
687,788
 

(1)Our available-for-sale securities are held at amortized cost.

(2)Includes investments classified as cash equivalents on our condensed consolidated balance sheet.

Temporarily Impaired Investments

Investments we considered to be temporarily impaired at September 30, 2015 were as follows (in thousands):

    
Less than 12 months of
temporary impairment
  
More than 12 months of
temporary impairment
  
Total temporary
impairment
 
  
Number of
Investments
  
Estimated
Fair Value
  
Unrealized
Losses
  
Estimated
Fair Value
  
Unrealized
Losses
  
Estimated
Fair Value
  
Unrealized
Losses
 
Corporate debt securities
  
247
  
$
293,774
  
$
(773
)
 
$
9,421
  
$
(16
)
 
$
303,195
  
$
(789
)
Debt securities issued by U.S. government agencies
  
7
   
40,497
   
(8
)
  
   
   
40,497
   
(8
)
Debt securities issued by states of the United States and political subdivisions of the states
  
96
   
50,648
   
(72
)
  
14,899
   
(108
)
  
65,547
   
(180
)
Total temporarily impaired securities
  
350
  
$
384,919
  
$
(853
)
 
$
24,320
  
$
(124
)
 
$
409,239
  
$
(977
)